(New York Times) – Moderna held further discussions with regulators and announced that the agency would accept the company’s application for approval of its flu vaccine that uses mRNA technology. The Food and Drug Administration reversed its decision on Moderna’s … Read More
https://bioethics.com/archives/101589
